Neurodegenerativ e Disorder Therapeutics
Market
Neurodegenerative Disorder Therapeutics Market
Scope: Industry Analysis, Market Size, Growth, Trends Till 2031
Request Sample Report
Neurodegenerative Disorder Therapeutics Market Size and Growth
The Neurodegenerative Disorder Therapeutics market is experiencing significant growth, driven by increasing patient populations and advancements in drug development. The market size reached approximately $XX billion in 2023, with projections indicating continued expansion. Key factors include rising healthcare investments and innovative therapies targeting diseases like Alzheimer's and Parkinson's. Request Sample Report
Companies Covered
(Covid 19 Impact Covered)
◍ Biogen, Inc.
◍ H. Lundbeck
◍ Sanofi S.A.
◍ Pfizer, Inc.
◍ F. Hoffmann- La Roche Ltd.
◍ Novartis AG
◍ GlaxoSmithKline PLC
◍ UCB S.A.
◍ Teva Pharmaceutical Industries Ltd.
◍ Merck KGaA
◍ Eisai Co., Ltd
◍ AbbVie Inc.
◍ Bayer AG
◍ Bristol Myers Squibb Company
The neurodegenerative disorder therapeutics market features key players like Biogen, H. Lundbeck, and Sanofi, focusing on innovative drugs and therapies for Alzheimer’s, Parkinson’s, and other conditions. Companies enhance market growth through R&D, strategic partnerships, and expanding product pipelines. Sales revenues include:
- Biogen: $11.4 billion
- Sanofi: $43.3 billion
- Pfizer: $41.9 billion
◍ Boehringer Ingeiheim International GmbH
Request Sample Report
Market Segmentation
By Application
◍ Multiple Sclerosis
◍ Parkinson`S Disease
◍ Alzheimer`S Disease
◍ Spinal Muscular Atrophy
◍ Huntington Disease
By Product
◍ Immunomodulators
◍ Interferons
◍ Decarboxylase Inhibitors
◍ Dopamine Agonists
◍ Others
◍ Other Neurodegenerative Disorders Request Sample Report
Market Growth
Request Sample Report
$ X Billion USD
